Many baby boomers don’t know they have hepatitis C until liver deteriorates
April 18, 2017
New Skin Cancer Drug Earns Fast-Tracked Approval 
April 18, 2017
Show all

Multiple Sclerosis Research Suggests Patients Need Tailored Therapies

Stem cells are showing promise in multiple sclerosis.

Brain stem cells from primary progressive multiple sclerosis (PPMS) patients lack the ability to repair brain damage and to trigger the maturation of protective myelin-producing cells, a surprising study with far-reaching implications indicates.

The study also showed that stem cells from individual patients reacted differently to compounds developed to trigger remyelination, suggesting that the underlying problem in PPMS may vary widely among patients. Myelin is a substance essential to the functioning of the nervous system. It is damaged in MS.

Differences in individual patients’ reactions to therapies may explain why most drugs developed for PPMS fail clinical trials despite looking promising in early research. The answer to this issue may be treating progressive MS patients in a personalized manner.

Read full article: Multiple Sclerosis Research Suggests Patients Need Tailored Therapies

Read Full Article: Multiple Sclerosis Research Suggests Patients Need Tailored Therapies

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.